Ironwood Pharmaceuticals   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Cambridge MA United States (1998)

Organization Overview

First Clinical Trial
2006
NCT00258193
First Marketed Drug
2015
lesinurad (zurampic)
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Ironwood Pharmaceuticals, Inc. | IRONWOOD PHARMS INC | Microbia | Microbia, Inc.